← Back to Search

Positive Psychosocial Intervention for Dementia (IPPI Trial)

N/A
Waitlist Available
Led By Katherine Abbott, PhD
Research Sponsored by Miami University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

IPPI Trial Summary

This trial tests if a positive psychosocial interaction can help reduce distress/depression in nursing home residents living with dementia. Care partners will interact 2x/week for 6 months and track impact.

Who is the study for?
This trial is for long-term nursing home residents with dementia and signs of distress or depression. Participants must have a low mental status score (0-12 on BIMS) and show certain behaviors like aggression, rejection of care, or restlessness. It's not for those planning to leave the nursing home within six months.Check my eligibility
What is being tested?
The study tests if it's possible to regularly provide Individualized Positive Psychosocial Interaction (IPPI) to these residents over six months, and if this can be tracked using electronic medical records. Care partners will conduct two tailored IPPI sessions weekly.See study design
What are the potential side effects?
Since IPPI involves social interaction tailored to individual preferences rather than medication, there are no typical drug side effects; however, participants may experience varying emotional responses based on their personal comfort with the interactions.

IPPI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral or Psychological Symptoms of Dementia or Depressive Symptoms
Secondary outcome measures
Staff-Reported

IPPI Trial Design

1Treatment groups
Experimental Treatment
Group I: experimentalExperimental Treatment1 Intervention
The experimental arm involves a brief positive interaction around a preferred activity or personal care routine.

Find a Location

Who is running the clinical trial?

Penn State UniversityOTHER
355 Previous Clinical Trials
125,649 Total Patients Enrolled
14 Trials studying Dementia
4,172 Patients Enrolled for Dementia
Miami UniversityLead Sponsor
13 Previous Clinical Trials
2,558 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,956 Total Patients Enrolled
265 Trials studying Dementia
23,623,303 Patients Enrolled for Dementia

Media Library

experimental Clinical Trial Eligibility Overview. Trial Name: NCT05980299 — N/A
Dementia Clinical Trial 2023: experimental Highlights & Side Effects. Trial Name: NCT05980299 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being accepted for this experiment?

"This trial is still actively searching for participants, as evidenced by the information provided on clinicaltrials.gov. The application was introduced to medical professionals on July 10th 2023 and has been updated most recently on August 7th of this same year."

Answered by AI

Are there numerous practices in Canada conducting research with this trial?

"Seven clinical trial sites have been identified, including The Trinity Community at Beavercreek in Beavercreek, The Chapel Hill Community in Canal Fulton and The Four Winds Community in Jackson. Other available locations are also listed."

Answered by AI

How many individuals are taking part in this trial at the moment?

"Affirmative. According to clinicaltrials, this trial is presently in the recruitment phase. The initial posting was on July 10th 2023 and it was recently updated on August 7th 2023. 108 patients are required from seven medical sites for enrollment."

Answered by AI

Is this clinical trial open to participants aged 30 and over?

"According to the inclusion requirements, individuals aged 18-110 are eligible for this study. Clinicialtrials.gov reports that 221 clinical trials target participants under 18 years of age and 1,274 studies focus on those 65 and older."

Answered by AI

Am I qualified to partake in this medical study?

"The requirements for enrolment in this clinical study include a diagnosis of dementia and an age between 18 to 110. At the present, 108 individuals are being sought after."

Answered by AI
~11 spots leftby Jun 2024